Home
overview

For the latest COVID-19 Travel restrictions and recommendations please click here

SMi’s inaugural Conference
Robotics and Automation in Pharma
February 21 - 22, 2022 | London, UK
-------------------------------------------------------------------------
This year more than any other has highlighted the heightened importance of robotic technology and automated processes in the Pharmaceutical Industry. This technology has exceptional promise, and we are close to seeing such capabilities realised. Robotics and Automation will cut expenditure devoted to manual labour, remove human error from the production process, and protect technicians from harmful materials, on top of diminishing risks of human-sourced microbiological contamination.

We are seeing a shift towards a fully digitalised industry, that not only promises to improve production efficiency, but also increase the value that humans add to the production pipeline. By automating tedious tasks people can be applied to processes that no machine can do -- while artificial intelligence can utilise data to reform manufacturing.

At this year’s event we will be showcasing the latest developments in the field surrounding the integration of Robotics and Automation into the Pharmaceutical Industry, from advancements in artificial intelligence and machine learning, to key insights into data and analytics, as well as the significant leaps in the robotic automation of some of Pharma’s most crucial processes.
Through recent case studies and interactive presentations, our attendees will discover how to best anticipate the next generation of Pharmaceuticals.

To register your interest or to get involved please contact: eshambler@smi-online.co.uk 
 

- DISCOVER the extent of the capabilities of fully-automated lines
- DISCUSS GMP requirements for the use of Robotics in aseptic manufacturing
- UNCOVER the issues to overcome in adopting automation to enable for digital transformation at scale
- ASSESS the potential role of automation in tackling the COVID-19 pandemic
- EXPLORE the possible industrial applications of Machine Learning and automation in Pharma
 


 

Chief Executives, Vice Presidents, Directors, Heads of Department, Senior Managers, and Principal Scientists specializing in:


- Robotics & Control
- CMC
- Continuous Processing
- Digital Strategy & Transformation
- Data Integrity
- Pharmaceutical Manufacturing
- Medical Devices
- Scale Up & Tech Transfer
- Quality Assurance/Control
- Regulatory Affairs & Licensing
- Compliance
- Emerging Technologies
- Risk Management
- Research & Development
- Sterilisation
- Supply Chain
- Research & Development
- Validation
- Process Monitoring
- Packaging
- Lifecycle Management

Previous attendees include:
 

Abbott; AbbVie; Allergy Therapeutics; Associates of Cape Cod; AstraZeneca; Baxter Healthcare; bioMerieux; BioPhorum; Boehringer Ingelheim; Boehringer Ingelheim Pharma GmbH & Co. KG; Charles River EMD; Christian Doppler Laboratory for Monitoring of Contaminants, University of Veterinary Medicine, Vienna; Copan; Copan Group; Copan Italia SpA; CTL - Mat; David P Elder Consultancy; European Patent Office; Fagron; Freeline; Fresenius Kabi; Fresenius Kabi UK Ltd; GSK; GSK Vaccines; GW Pharma ; King's College London ; Kite Pharma ; Lonza; MeiraGTx; Meriagtx; Mettler Toledo; Mettler Toledo Ltd; Mettler-Toledo Ltd; Mettler-Toledo Thornton; MHRA; MIcrobiologics; Microgenetics Ltd; Novo Nordisk; Oxford Biomedica Ltd; Paul Ehrlich Institut; PHSS: Pharmaceutical & Healthcare Sciences Society; Reading Scientific Services Ltd; Reading Scientific Services Ltd (RSSL); Regeneron Pharmaceuticals Inc.; RSSL; Sanofi-Aventis Deutschland GmbH; SDA Pharma; Steris Corporation; Techniconsult Firenze SRL; University of Veterinary Medicine Vienna; VCCN/Brookhuis Applied Data Intelligence; Veltek Associates, Inc.;

 

Conference programme

8:00 Registration & Coffee

9:00 Chair's Opening Remarks

Timothy Spicer

Timothy Spicer, Senior Scientific Director, Scripps Research
View Bio

9:10 GMP Requirements for the use of Robotics in aseptic manufacturing

Richard Denk

Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG
View Bio

• Requirements according to the newest draft of the EU GMP Annex 1
• Contamination Control Strategy using Robotics
• Cleaning, and Cross Contamination prevention
 

9:50 Implementing the QC Lab of the Future through automation

Aude Smeets

Aude Smeets, Analytical technical expert Automation, GSK Vaccines

• Challenge of Vaccine QC laboratories, how automation could help
• Expected benefits from Automation in QC labs
• Automation project implementation stream (in a cGMP environment)
• How to support Automation integration?
 

10:30 Morning Coffee

11:00 Process Mapping to identify automation opportunities in pharmaceutical manufacturing

Frank Thielmann

Frank Thielmann, Global Program Associate Director, Novartis
View Bio

• Identification of automation opportunities in drug product manufacturing
• Use of process mapping in various processes and areas
• Outcomes and lessons learnt
 

11:40 Leading Edge Academic and Industrial Screening with Fully Automated Platforms

Timothy Spicer

Timothy Spicer, Senior Scientific Director, Scripps Research
View Bio

• This talk will include an evolutionary prospective of robotically enabled small molecule HTS, what has transformed our abilities to be successful at it, and future automation initiatives
• Systems configurations including highly intricate, yet flexible automation and informatics platforms are crucial to success uHTS; This seminar with detail all facets that enable industrial screening in an academic setting
• You will hear about how we integrate new technologies onto the fully automated platforms to enable 3D screening approaches to stay ahead of the curve
• This presentation will demonstrate how we leverage technologies to enable screening more physiologically relevant human models of neuronal disease
 

12:20 Networking Lunch

13:20 Enabling digital transformation at scale

Carsten Lutzhøft

Carsten Lutzhøft, Senior Director, Process Digitalisation, Technology Enablement Center, Novo Nordisk A/S

• Digital in a pharma production context
• What enabled us to scale digital automations, AI, AR in Novo Nordisk
• Use cases from across the supply chain
 

14:00 Laying the Foundation of Modern Robotics at Roche

Markus Stubchen

Markus Stubchen, Global Technical Lead Large Molecules Drug Product and Robotic Network Team, F. Hoffmann-La Roche Ltd.
View Bio

• Facing a changing portfolio with increased focus on personalized cancer vaccines, orphan drugs and C&G-T Roche needs to develop a novel facility of the future concept that will support fast and agile production environments which are more effective, with short change over phases and at the same time run at significantly reduced cost and still adhere to highest quality standards and Health Authority expectations
• The networkwide Roche Robotics Network Team acts as an interdisciplinary team of specialists from global and site functions that identifies and explores state-of-the-art robotic solutions that are eligible to be key elements in the Biomanufacturing for Tomorrow design (BM4T)
• One of the current efforts includes the establishment of what Roche calls “sandboxes” which are test environments outside of the GMP manufacturing space enabling try fast-fail fast-approaches in order to be fast and agile when it comes to the identification of appropriate technology for the new facility design
 

14:40 Afternoon Tea

15:10 Automation’s Role on Managing Covid Adverse Events

• Bullet points to be confirmed

Namita Pande

Namita Pande, Sr. Manager, Pfizer
View Bio

Rupinder Bhullar

Rupinder Bhullar, Sr. Manager, Pfizer
View Bio

15:50 Beyond Robotics: State of the art automation solutions for Pharma

16:30 Chair’s Closing Remarks and Close of Day One

Timothy Spicer

Timothy Spicer, Senior Scientific Director, Scripps Research
View Bio

8:30 Registration & Coffee

9:00 Chair's Opening Remarks

Martin Dueblin

Martin Dueblin, Business Owner, One One Eleven GmbH
View Bio

9:10 The Digital Robot Pharma Fab

Martin Dueblin

Martin Dueblin, Business Owner, One One Eleven GmbH
View Bio

• The enormous area of robotic, AI and full digitalization
• The wide area of Logistic
• Robots for Pharma production
• Compounding, a new field for robots
• Laboratories are not a stepchild in regard to industry X.Y
• And now back to the overall factory, your future standard module or IT driven function block
 

9:50 Accelerating the Biopharm Discovery Process with Automation

Zoe Hughes-Thomas

Zoe Hughes-Thomas, Head Medicine Design Automation Team, GlaxoSmithKline

• Bullet points to be confirmed

10:30 Morning Coffee

11:00 Panel Discussion: Robotics and Automation in Pharma

• Gartner’s magic quadrant and the niche players contribution to Pharma
• Present Limitations and challenges with RPA and effective means to share the lessons learnt
• Established Computer System Validation (CSV) for RPA enabled GxP systems – Industry best practices
• If we consider benchmarking, what is the common use case which can be quickly adapted by the Pharma sector towards automation?
• How do you foresee the future business model for RPA? Will this be adapted as an open marketplace just like Amazon Web Services (AWS), Microsoft’s Azure, Google Cloud Platform (GCP), etc.?
 

Vinod Das

Vinod Das, Associate Director, Bayer

Frank Thielmann

Frank Thielmann, Global Program Associate Director, Novartis
View Bio

Anders Woelders

Anders Woelders, Senior Manager, Novo Nordisk A/S
View Bio

Tim Willittes

Tim Willittes, Cognitive RPA Lead, Johnson & Johnson
View Bio

11:40 Cognitive RPA in Pharmaceutical R&D

Tim Willittes

Tim Willittes, Cognitive RPA Lead, Johnson & Johnson
View Bio

• What is Cognitive RPA?
• A framework for generating significant value from Cognitive RPA
• Case Study: Using NLP to draft Subject Safety Narratives
• How to get started or level up your automation journey
 

12:20 Networking Lunch

13:20 Overcoming challenges with Machine Learning in a GMP context

Anders Woelders

Anders Woelders, Senior Manager, Novo Nordisk A/S
View Bio

• Introduction
• Setting the scene – Why is using ML in a GMP environment difficult
• Use Case – Receiving external CoA’s using Machine Learning
• Learnings
 

14:00 Advantages of Closed Systems: overcoming issues in adopting automation

Kuan Duprey

Kuan Duprey, Sr. Process Engineering III, Kite Pharma

• Automated Apheresis in personalised cell therapy: how to transition from 100% manual to a semi-closed system
• Compliance challenges and Environmental Considerations
• How closed projects have allowed for increased therapy
• Decreasing the application of harsh disinfectants lowering the risk of growth interference
 

14:40 Afternoon Tea

15:10 Continuous and Controlled Pharmaceutical Freeze Drying – Vial-by-vial

Sune Andersen

Sune Andersen, Principal Scientist Drying Processes, Novo Nordisk A / S

• Optimization possibilities for freeze drying technologies
• Application of continuous manufacturing for drying technologies
• Continuous Single Vial Freeze Drying technology
 

15:50 Chair’s Closing Remarks and Close of Day Two

Martin Dueblin

Martin Dueblin, Business Owner, One One Eleven GmbH
View Bio

+

FEATURED SPEAKERS

Anders Woelders

Anders Woelders

Senior Manager, Novo Nordisk A/S
Aude Smeets

Aude Smeets

Analytical technical expert Automation, GSK Vaccines
Carsten Lutzhøft

Carsten Lutzhøft

Senior Director, Process Digitalisation, Technology Enablement Center, Novo Nordisk A/S
Frank Thielmann

Frank Thielmann

Global Program Associate Director, Novartis
Kuan Duprey

Kuan Duprey

Sr. Process Engineering III, Kite Pharma
Markus Stubchen

Markus Stubchen

Global Technical Lead Large Molecules Drug Product and Robotic Network Team, F. Hoffmann-La Roche Ltd.
Martin Dueblin

Martin Dueblin

Business Owner, One One Eleven GmbH
Namita Pande

Namita Pande

Sr. Manager, Pfizer
Richard Denk

Richard Denk

Senior Consultant Aseptic Processing & Containment, SKAN AG
Rupinder Bhullar

Rupinder Bhullar

Sr. Manager, Pfizer
Sune Andersen

Sune Andersen

Principal Scientist Drying Processes, Novo Nordisk A / S
Tim Willittes

Tim Willittes

Cognitive RPA Lead, Johnson & Johnson
Timothy Spicer

Timothy Spicer

Senior Scientific Director, Scripps Research
Vinod Das

Vinod Das

Associate Director, Bayer
Zoe Hughes-Thomas

Zoe Hughes-Thomas

Head Medicine Design Automation Team, GlaxoSmithKline

Anders Woelders

Senior Manager, Novo Nordisk A/S
Anders Woelders

Anders Woelders has been part of Novo Nordisk for the past 4 years where he has supported in establishing PS Process Digitalisation, and introducing new technology platforms to the company.
Currently Anders drives a portfolio of automation/digitalisation initiatives primarily focusing on such platforms as Microsoft Power Platform and UiPath to the product supply part of Novo Nordisk.
 

Aude Smeets

Analytical technical expert Automation, GSK Vaccines
Aude Smeets

Carsten Lutzhøft

Senior Director, Process Digitalisation, Technology Enablement Center, Novo Nordisk A/S
Carsten Lutzhøft

Frank Thielmann

Global Program Associate Director, Novartis
Frank Thielmann

Dr Thielmann has a PhD in Physical Chemistry/ Material Science from the University of Duesseldorf, Germany. Frank joined Novartis Pharmaceutical Development (Basel, Switzerland) in July 2007 as Formulation Lab Head. From 2009 until 2011 he managed the pharmaceutical development group in the UK. Upon his return to Switzerland he joined Novartis Technical Operations where he was managing the setup of a new solid dosage form manufacturing facility and the transfer of the corresponding portfolio before moving to the Biotechnology department as global Leader for PMO & Operational Excellence in November 2016, In this role Frank had an additional responsibility as Operational Excellence Head of the new Novartis manufacturing facility for Cell & Gene Therapeutics in Switzerland.

In November 2019, Dr Thielmann moved to a new responsibility at Takeda Manufacturing & Supply as Operational Excellence Director, where he is responsible for the implementation of process improvement in the manufacturing of a wide portfolio ranging from small molecules to ATMPs with special focus on digitalization & automation.

Dr Thielmann is member of the Steering Committee of the Material Science and Biotherapeutics Focus Group in the British Academy of Pharmaceutical Sciences.
 

Kuan Duprey

Sr. Process Engineering III, Kite Pharma
Kuan Duprey

Markus Stubchen

Global Technical Lead Large Molecules Drug Product and Robotic Network Team, F. Hoffmann-La Roche Ltd.
Markus Stubchen

Markus started his career in 1996 with the Hoechst AG, Frankfurt, Germany, as a project engineer for DS facilities in the field of e-coli-fermentation, downstream processing and purification.

Since 2008, he held positions at F. Hoffmann - La Roche, Basel, Switzerland, as Head of Plant Maintenance and Compounding of Basel's Parenterals Production and Head of Blister Packaging Operations in Kaiseraugst. After joining Global Engineering in 2016 Markus took over the role of the Global Technical Lead Large Molecules Drug Product, which was later moved to PTI. In this function, he collaborates with global and site functions from engineering, MSAT, procurement and quality as well as equipment suppliers to leverage the implementation of innovative technologies and harmonization of processes across the company's manufacturing sites in Europe and the US. The current focus of his activities is the identification of innovative robotic technologies and deployment of robotic systems in commercial DS and DP manufacturing and packaging. In this context, Markus leads the Robotics Network Team and engages in the ISPE Special Interest Group Robotics and the Aseptic CoP.
 

Martin Dueblin

Business Owner, One One Eleven GmbH
Martin Dueblin

Martin Düblin is a mechanical and process engineer and highly experienced in the field of the life science industry, infrastructure and health care community. For more than 25 years, he has been involved in many major strategic projects in Europe, North and South America, North Africa and Asia for laboratories, pilot scale installations, production, office buildings, hospitals, education, warehouse, energy / utilities and waste management. Several products and brands have been launched under his responsibility. In his role as specialist for various life science companies, Martin has provided support in all kinds of technical «revolutions» such as full digital production with the help of robotics and AI, delivering high quality products, preparing the disruptive transition and ensuring global competitiveness.

Namita Pande

Sr. Manager, Pfizer
Namita Pande

Namita works as an Engagement and Portfolio Lead for a world of true Robotic Process Automation powered solutions which include engaging with Business and Client Partners to visualize/ discover solutions that can augment human capabilities. By automating repetitive, mundane, time-consuming, and manual processes, her team is able to reduce human error and create room for meaningful work which increases creativity and innovation within the team. She believes that “the future workforce will be a combination of human and digital workers, working together as a team in a variety of ways – integrated, augmented, and collaborative”.

Richard Denk

Senior Consultant Aseptic Processing & Containment, SKAN AG
Richard Denk

Richard Denk is working at the company SKAN AG, headquartered in Allschwil Switzerland in the position Senior Consultant Aseptic Processing & Containment. Richard is member of the PDA Isolator Expert Group, ISPE Sterile Product Processing Group, Chair of the ISPE Containment DACH, the ISPE SIG Robotic and Co-Chair ISPE SIG Bio on Innovations and Technology. Furthermore, Richard is Member of the ISO TC 198 WG-9 Aseptic Isolator Group.

Rupinder Bhullar

Sr. Manager, Pfizer
Rupinder Bhullar

Rupinder has 20+ year at Pfizer providing leadership in delivering complex projects in Robotics Process automation (RPA), Business Intelligence and Analytics, Master Data (SAP ERP) and HR. He is passionate about AI/RPA/Data Science and has led the setting up and adoption of RPA service at his company. This service was rated in the top tier of Robotic operating model by Blue Prism and has contributed in processing of large amounts of data for COVID trials in a very short period of time. He was awarded UpJohn Award for his service to COVID initiative.

Rupinder is a seasoned IT leader with diverse experience in Robotic Process Automation/ Data Warehousing/ Master Data Management/ Data Integration/ Business Intelligence and Analytics with emphasis on delivery, support, operational optimization, standards, compliance and best practices.

A graduate of Stevens Institute of Technology, NJ (MBA) and Punjab University, India (Masters in Engineering), Rupinder is a champion of continuous improvement and has Green Belt from Six Sigma. Rupinder is also Certified Agile leader, Certified Scrum Master and Certified Product Owner.
 

Sune Andersen

Principal Scientist Drying Processes, Novo Nordisk A / S
Sune Andersen

Tim Willittes

Cognitive RPA Lead, Johnson & Johnson
Tim Willittes

Tim is the Cognitive Automation Lead at Janssen. In this role, Tim is responsible for evaluating and implementing advanced automation solutions across R&D, leading to transformational process innovation and delivering for the future.

Tim joined J&J in 2018, where he worked at Janssen to help launch Intelligent Automation, which introduces “digital workers” to deliver efficiencies in a rapid cost-effective manner. During his time at J&J, Tim also led the technical build of a global supply chain analytics platform to improve J&J customer reliability on-time and in-full (OTIF-D).

Tim earned his B.S. in Operations Research and Information Engineering from Cornell University. He currently resides in Los Angeles, CA.
 

Timothy Spicer

Senior Scientific Director, Scripps Research
Timothy Spicer

Dr. Tim Spicer is a faculty member and Senior Scientific Director in the Department of Molecular Medicine at Scripps Research in Florida. Tim has more than 30 years of experience in drug discovery, including 10 years at Bristol-Myers Squibb. He has been at Scripps Florida since its inception in 2005. Tim is currently the Director of HTS and Discovery Biology and co-directs the screening center at Scripps. Germane to this talk, he supervises HTS & related efforts including the advanced development of robotically enabled systems for use in High Throughput Screening. He has authored >120 drug-discovery related publications and is an inventor on 3 patents, including clinically useful drugs.

Vinod Das

Associate Director, Bayer
Vinod Das

Zoe Hughes-Thomas

Head Medicine Design Automation Team, GlaxoSmithKline
Zoe Hughes-Thomas

VENUE

Venue To Be Confirmed

London, United Kingdom

A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
HOTEL BOOKING FORM

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Venue To Be Confirmed

London
United Kingdom

Venue To Be Confirmed

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SMi.
Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out